CYAN 7.50 Cyanotech Corp $CYAN Hit a 52 week high of 7.50

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
CYAN 7.50 Cyanotech Corp $CYAN Hit a 52 week high of 7.50 Closing the day 09:41 at 7.50 +0.47 +6.69% With a day low of 7.25 and a total volume of 11,221.

CYAN Recent Posts: http://investorshangout.com/Cyanotech-Corp-CYAN-53859/

CYAN Cyanotech Corp Recent Headline News

Nasdaq stocks posting largest percentage increases
AP - Fri Nov 14, 12:17PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
NVEE: 11.90 (+1.41), SSO.TO: 5.91 (-0.03), BRDR: 8.01 (-0.02), CYAN: 7.25 (+0.22), SSRI: 5.23 (-0.02), SZMK: 6.17 (+0.09), AREX: 12.05 (-0.95)

Nasdaq stocks posting largest volume increases
AP - Tue Nov 11, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
HEAR: 3.93 (-0.03), LSBK: 13.00 (+0.25), VSAR: 18.99 (+0.45), SANW: 3.62 (-0.04), URRE: 2.26 (-0.02), EDUC: 4.16 (-0.13), MCEP: 15.66 (-0.51), CYAN: 7.25 (+0.22), DNDN: 0.13 (+0.02), SUMR: 2.85 (-0.02), CRTN: 4.30 (unch)

Midday gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 11:45AM CST

FSM: 4.44 (+0.01), HEAR: 3.93 (-0.03), JRJC: 6.86 (-0.49), CVO: 1.79 (-0.02), AAOI: 12.03 (-0.14), UNIS: 2.83 (-0.06), HIIQ: 7.86 (-0.39), CYAN: 7.25 (+0.22), PTX: 11.00 (+0.05), TRMR: 2.71 (-0.10), PRKR: 1.13 (unch), SUMR: 2.85 (-0.02), VSLR: 11.67 (-0.26), RVP: 4.28 (+0.40), ASCMA: 53.99 (-0.21), ICUI: 85.67 (-0.04), CALL: 8.86 (+0.24), DMD: 5.43 (-0.22), AST: 3.93 (+0.13), ASEI: 46.35 (+0.23)

Cyanotech EPS of $0.03
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 11:31PM CST

CYAN: 7.25 (+0.22)

Cyanotech Reports Financial Results for the Second Quarter and First Half of Fiscal Year 2015
Business Wire - Mon Nov 10, 6:15PM CST
Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, today announced financial results for the second quarter and first six months of fiscal year 2015, ended September 30, 2014.
CYAN: 7.25 (+0.22)

Cyanotech Adds 2,280 Solar Array Panels; Reduces Greenhouse Emissions by 791 Metric Tons of Carbon Dioxide Per Year and Annual Electricity Costs by 10 Percent
Business Wire - Fri Oct 31, 12:10PM CDT
Cyanotech Corporation (Nasdaq Capital Market: CYAN), a global producer of effective, natural microalgae nutritional supplements, announced the installation of its new solar array by Neighborhood Power Company (NPC). The 2,280 panel array sits on 1.3 acres of Cyanotech's 90-acre microalgae farm, and will produce 1,147,000 kilowatt hours of electricity each year, which Cyanotech will purchase under a Power Purchase Agreement (PPA). The energy production is sufficient to power the entire farm's production during daylight hours, and will reduce Cyanotech's electricity costs by 10 percent.
CYAN: 7.25 (+0.22)

Cyanotech Names Gerry Watts as Chief Operations Officer
Business Wire - Mon Aug 18, 7:00AM CDT
Cyanotech Corporation (Nasdaq Capital Market: CYAN) has named Gerard "Gerry" Watts to fill a newly-created position as Chief Operations Officer, effective today.
CYAN: 7.25 (+0.22)

Cyanotech Reports Financial Results for the First Quarter of Fiscal Year 2015
Business Wire - Thu Aug 14, 7:00AM CDT
Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, today announced financial results for the first quarter of fiscal year 2015, ended June 30, 2014.
CYAN: 7.25 (+0.22)

Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2014
Business Wire - Fri Jun 27, 8:00AM CDT
Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, today announced financial results for the fourth quarter and fiscal year 2014, ended March 31, 2014.
CYAN: 7.25 (+0.22)

TerraX Closes Private Placement for $675,000
Marketwire - Wed Feb 12, 2:10PM CST
TerraX Minerals Inc. (TSX VENTURE: TXR)(FRANKFURT: TX0) has closed its previously announced non-brokered private placement of 1,500,000 units at $0.45 per unit, with two placees, for gross proceeds of $675,000. Each unit consists of one common share and one-half of one share purchase warrant, with each full warrant entitling the holder to purchase an additional common share at an exercise price of $0.51 per share until February 12, 2016. The shares and any shares acquired on the exercise of warrants will be subject to a hold period expiring on June 13, 2014. Finders' fees of $31,500 were paid with respect to this placement along with the issuance of 70,000 finders' warrants exercisable at $0.51 until February 12, 2016.
CYAN: 7.25 (+0.22), FMC: 56.55 (-0.07), TXR.VN: 0.310 (+0.010)

Cyanotech Reports Financial Results for the Third Quarter of Fiscal Year 2014
Business Wire - Thu Feb 06, 7:00AM CST
Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, today announced financial results for the third quarter and first nine months of fiscal year 2014, ended December 31, 2013.
CYAN: 7.25 (+0.22)

Cyanotech Corporation names Walter B. Menzel as director
M2 - Mon Sep 09, 4:34AM CDT
The stockholders of Cyanotech Corporation (Nasdaq Capital Market: CYAN), a microalgae technology company, announced on Friday the appointment of Walter B. Menzel as its director.
CYAN: 7.25 (+0.22)

Cyanotech Stockholders Elect Walter B. Menzel as a Director
Business Wire - Fri Sep 06, 12:00PM CDT
Stockholders of Cyanotech Corporation (Nasdaq Capital Market: CYAN) elected Walter B. Menzel as a Director at the Annual Meeting on August 29, 2013.
CYAN: 7.25 (+0.22)

OTC Daily Alert Stock Watch Cyanotech Corporation (NASDAQ: CYAN)
WorldStockWire - Mon Sep 02, 5:16PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
CYAN: 7.25 (+0.22)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 92

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 69

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 147

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 143

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 303

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 185

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 292

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 96

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 146

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 239

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading

Top 5 Most Recently Viewed Articles

Heights Wellness Retreat: A Bold Step Towards Holistic Wellness

Updated Category News Views 227

Heights Wellness Retreat: A New Era of Wellness In a landmark announcement during their annual summit, Massage Heights unveiled a significant transformation that redefines their brand identity. The brand, known for its commitment to wellness over the past two decades, will now operate under the name Heights Wellness Retreat. This evolution is more than just a new name; it...

Continue Reading
GeneDx Strengthens Leadership with New COO Appointment

Updated Category News Views 168

GeneDx Welcomes Bryan Dechairo as Chief Operating Officer GeneDx (NASDAQ: WGS) has made headlines with the appointment of Bryan Dechairo as its new Chief Operating Officer. This strategic decision aims to enhance operations and drive the company’s next phase of growth. Enhancing Operations for Future Success As COO, Dechairo will oversee critical areas including Product...

Continue Reading
FreightCar America to Share Q1 2025 Financial Results Soon

Updated Category News Views 130

FreightCar America Prepares for Q1 2025 Earnings Announcement FreightCar America, Inc. (NASDAQ: RAIL), a prominent player in the manufacturing of railroad freight cars, is gearing up to release its financial results for the first quarter of 2025. This important announcement is scheduled for after the market closes on a Monday, allowing investors and stakeholders to digest...

Continue Reading
Empowering Veterans: United Food Group's New Initiative

Updated Category News Views 129

United Food Group Unveils New Employment Initiative United Food Group, a noted developer and manufacturer of coffee equipment, powdered condiments, and beverages, has announced an innovative employment initiative designed to support wounded veterans and first responders. This program not only aims to empower these individuals but also provides them with specialized...

Continue Reading
US Futures Gain on Peace Talk Hopes Amid Market Developments

Updated Category News Views 206

U.S. Stock Futures Trend Upward U.S. stock futures saw an increase following the extended weekend, coming off a mixed trading day last Friday. The day off for Presidents Day allowed investors to reassess their positions. As a result, all four major indices posted gains in premarket trading. Investor Focus on Macro Conditions In today's trading, investors will closely...

Continue Reading